AI assistant
Sabre Insurance Group PLC Director's Dealing 2021
5341_dirs_2021-03-30_c2398294-40b8-4d63-9ba7-d821f939e941.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information 
RNS Number : 0004U
Sabre Insurance Group PLC
30 March 2021
30 March 2021
Sabre Insurance Group plc ("Sabre" or the "Company")
Notification of transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
Awards under the Company's Deferred Bonus Plan
The Company announces that on 30 March 2021, the following directors and PDMRs of the Company were, subject to the rules of the Sabre 2017 Deferred Bonus Plan, each granted a conditional award (the 'DBP Award') of ordinary shares of £0.001 in the Company, in respect of bonuses earned for the financial year ended 31 December 2020 as detailed below:
| Name | Position | Number of shares subject to award |
| Geoff Carter | Chief Executive Officer | 69,610 |
| Anneka Kingan | Chief Risk Officer and Company Secretary | 34,083 |
| James Ockenden | Chief Actuary | 49,136 |
| Trevor Webb | Claims Director | 53,231 |
| Adam Westwood | Chief Financial Officer | 40,947 |
Subject to the rules of the Sabre 2017 Deferred Bonus Plan, the DBP Awards will vest on the second anniversary of the grant date.
This notification is made pursuant to Article 19 of the EU Market Abuse Regulation.
Additional Information:
Anneka Kingan - Company Secretary
PDMR transaction notification
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Geoff Carter
2
Reason for the notification
a)
Position/status
Chief Executive Officer
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Sabre Insurance Group Plc
b)
LEI
2138006RXRQ8P8VKGV98
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
A non-transferable conditional award of ordinary shares in the Company under the Sabre 2017 Deferred Bonus Plan. No consideration will be paid by the PDMR on the grant or vesting of the conditional award.
Identification code
GB00BYWVDP49
b)
Nature of the transaction
Grant of conditional award
c)
Price(s) and volume(s)
| Price per share | Volume |
| £2.415 | 69,610 |
d)
Aggregated Information
Volume
Price
| Volume | Price per share |
| 69,610 | £2.415 |
e)
Date of transaction
30 March 2021
f)
Place of transaction
London Stock Exchange (XLON)
PDMR transaction notification
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Anneka Kingan
2
Reason for the notification
a)
Position/status
Chief Risk Officer and Company Secretary
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Sabre Insurance Group Plc
b)
LEI
2138006RXRQ8P8VKGV98
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
A non-transferable conditional award of ordinary shares in the Company under the Sabre 2017 Deferred Bonus Plan. No consideration will be paid by the PDMR on the grant or vesting of the conditional award.
Identification code
GB00BYWVDP49
b)
Nature of the transaction
Grant of conditional award
c)
Price(s) and volume(s)
| Price per share | Volume |
| £2.415 | 34,083 |
d)
Aggregated Information
Volume
Price
| Volume | Price per share |
| 34,083 | £2.415 |
e)
Date of transaction
30 March 2021
f)
Place of transaction
London Stock Exchange (XLON)
PDMR transaction notification
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
James Ockenden
2
Reason for the notification
a)
Position/status
Chief Actuary
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Sabre Insurance Group Plc
b)
LEI
2138006RXRQ8P8VKGV98
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
A non-transferable conditional award of ordinary shares in the Company under the Sabre 2017 Deferred Bonus Plan. No consideration will be paid by the PDMR on the grant or vesting of the conditional award.
Identification code
GB00BYWVDP49
b)
Nature of the transaction
Grant of conditional award
c)
Price(s) and volume(s)
| Price per share | Volume |
| £2.415 | 49,136 |
d)
Aggregated Information
Volume
Price
| Volume | Price per share |
| 49,136 | £2.415 |
e)
Date of transaction
30 March 2021
f)
Place of transaction
London Stock Exchange (XLON)
PDMR transaction notification
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Trevor Webb
2
Reason for the notification
a)
Position/status
Claims Director
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Sabre Insurance Group Plc
b)
LEI
2138006RXRQ8P8VKGV98
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
A non-transferable conditional award of ordinary shares in the Company under the Sabre 2017 Deferred Bonus Plan. No consideration will be paid by the PDMR on the grant or vesting of the conditional award.
Identification code
GB00BYWVDP49
b)
Nature of the transaction
Grant of conditional award
c)
Price(s) and volume(s)
| Price per share | Volume |
| £2.415 | 53,231 |
d)
Aggregated Information
Volume
Price
| Volume | Price per share |
| 53,231 | £2.415 |
e)
Date of transaction
30 March 2021
f)
Place of transaction
London Stock Exchange (XLON)
PDMR transaction notification
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Adam Westwood
2
Reason for the notification
a)
Position/status
Chief Financial Officer
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Sabre Insurance Group Plc
b)
LEI
2138006RXRQ8P8VKGV98
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
A non-transferable conditional award of ordinary shares in the Company under the Sabre 2017 Deferred Bonus Plan. No consideration will be paid by the PDMR on the grant or vesting of the conditional award.
Identification code
GB00BYWVDP49
b)
Nature of the transaction
Grant of conditional award
c)
Price(s) and volume(s)
| Price per share | Volume |
| £2.415 | 40,947 |
d)
Aggregated Information
Volume
Price
| Volume | Price per share |
| 40,947 | £2.415 |
e)
Date of transaction
30 March 2021
f)
Place of transaction
London Stock Exchange (XLON)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHLBLFXFXLEBBZ